Antitumor profiles and cardiac electrophysiological effects of aurora kinase inhibitor ZM447439.

Lee, Hyang-Ae; Kwon, Miso; Kim, Hyeon-A; Kim, Ki-Suk

Lee, Hyang-Ae; Kwon, Miso; Kim, Hyeon-A; Kim, Ki-Suk.

Afiliación

Lee HA; R&D Center for Advanced Pharmaceuticals & Evaluation, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Kwon M; R&D Center for Advanced Pharmaceuticals & Evaluation, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Kim HA; Fertility Center, CHA Bunding Medical Center, CHA University, Seongnam 13496, Korea.
Kim KS; R&D Center for Advanced Pharmaceuticals & Evaluation, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.

Korean J Physiol Pharmacol ; 23(5): 393-402, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31496876

Palabras clave

Anticancer agents; Aurora kinases inhibitor; Cardiotoxicity; Efficacy testing; ZM447439

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Korean J Physiol Pharmacol Año: 2019 Tipo del documento: Article